TPG Capital Asia acquires major stake in Taiwan clinical trial firm

Taiwan |  News | 0 Comment | 04 Sep, 2017

TPG Capital Asia, a global investment firm has acquired a majority stake in Taiwan-based clinical trial services provider OPC Holding Company. The deal terms were not disclosed. The acquisi...Read more

Appier secures series C funding

Taiwan |  News | 0 Comment | 30 Aug, 2017

Appier, a leading artificial intelligence (AI) company, has secured Series C investment of $33 million from SoftBank Group Corp., LINE Corporation, NAVER Corporation, Singapore-based EDBI a...Read more

“BioTaiwan's growth is a reflection of the success of Taiwan biotech as a whole in recent years.”

Taiwan |  Opinion | 0 Comment | 08 Aug, 2017

Singapore - In Taiwan, biotech is finally booming, and new companies, service providers and manufacturing facilities are emerging to fill rapidly growing industry needs. BioSpectrum As...Read more

Biomedic Consulting inks strategic deal with Taiwan Biomed

Taiwan |  News | 0 Comment | 25 Jul, 2017

Singapore: Biomedic consulting, the Taiwanese Medical Devices and Biotechnology consulting firm  has inked a strategic partnership deal with  Taiwan Biomed. The partnership aims t...Read more

Taipei hosts BioTaiwan 2017 with 600 firms' participation

Taiwan |  News | 0 Comment | 17 Jul, 2017

BioTaiwan 2017, the annual biotech-themed convention, organized by Taiwan Bio Industry Organization took place between June 28 to July 2 in Taipei World Trade Center – Nangang Exhibit...Read more

Taiwan institutes team up for biomedical research

Taiwan |  News | 0 Comment | 06 Jul, 2017

The Development Center for Biotechnology (DCB), the Medical and Pharmaceutical Industrial Technology Development Center (PITDC), and Taipei Medical University (TMU), three of Taiwan's premi...Read more

Snake venom may replace aspirin

Taiwan |  News | 0 Comment | 13 Jun, 2017

Scientists at the National Taiwan University have found that snake venom can provide a safer alternative to drugs like aspirin that help prevent blood clots in heart disease patients. Anti...Read more

Chugai receives Taiwan nod for Alecensa

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2017

Singapore: Japan's leading pharma giant Chugai pharmaceuticals announced that its subsidiary Chugai Pharma Taiwan has received approval for the anti-cancer agent, alectinib hydrochloride fr...Read more

Taipei firm works to cure cancer through mushrooms

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Feb, 2017

Singapore: Taipei based Zhenjuntang Biotechnology aims to cure cancer through a mushroom -stout camphor fungus, also called "niu zhang zhi" in Chinese. Since its establishment in 2009, the ...Read more

Taiwan govt's new plans to bolster the biomedical sector

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2016

Singapore: In a bid to transform Taiwan into a center of biotechnology and medical R&D in Asia, the government has approved a biomedical promotion plan budgeted at NT$10.94 billion (US$...Read more

Research provides deeper understanding of plant aging

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2012

Singapore: A research team lead by Dr Hsou-min Li, a research fellow at the Institute of Molecular Biology in Taiwan has discovered that the import of proteins into chloroplasts in plants i...Read more

Taiwan to beef up medical cooperation with the ASEAN

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2016

Singapore: As a part of the Taiwan government's New Southbound Policy, Minister of Science and Technology Mr Yang Hung-duen said that Taiwan aims to medical exports and expand cooperation o...Read more

TaiGen Biotech's pneumonia drug receives CFDA approval

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jun, 2016

Singapore: The China Food and Drug Administration (CFDA) has approved to market TaiGen Biotechnology's novel antibiotic, Taigexyn (nemonoxacin), in mainland China. TaiGen Biotechnology is a...Read more

TWi receives FDA approval for generic Alzheimer's drug

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Nov, 2014

Singapore: FDA has given a nod to TWi pharmaceuticals ANDA for Donepezil Hydrochloride Tablets USP, 23 mg, the generic equivalent to Eisai's Aricept 23mg. The drug is used to treat Alzheime...Read more

Taiwan discovers new molecule that can arrest breast cancer spread

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 04 May, 2016

Singapore: Taiwan's premier research institution, Academia Sinica has developed a new material (Q2-3) that can arrest the spread of breast cancer cells. As per reports, Q2-3 prevents the sp...Read more

Orient, NanoCarrier sign deal for Nanoplatin trial

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2012

Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreement for conducting registration trials of Nanoplatin in Taiwan, Singap...Read more

Scinopharm's net income drops as sales slow down

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2015

Singapore: Declaring quarterly results, Taiwan's pharmaceutical giant Scinopharm said that its net income last quarter declined by 32 percent year-on-year to $4.15 million. The company said...Read more

TWi Biotech secures patent for diabetes drug in Korea

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Oct, 2015

Singapore: Taiwan based TWi Biotechnology has been granted patent in Korea for it diabetes drug, AC-201, from the Korean Intellectual Property Office. The patent includes AC-201 or its pha...Read more